|Market Size in 2022||Market Forecast in 2030||CAGR (in %)||Base Year|
|USD 3.91 Billion||USD 7.56 Billion||8.60%||2022|
Specific Pathogen Free (SPF) Animals Market
The global Specific Pathogen Free (SPF) Animals market size was evaluated at $3.91 billion in 2022 and is slated to hit $7.56 billion by the end of 2030 with a CAGR of nearly 8.60% between 2023 and 2030.
The specific pathogen free animals is a term that is especially used for the animals that are free from pathogens and are used in the laboratory for testing purposes. These animals are kept in a highly monitored environment so that they are not infected by any type of pathogens. These animals are kept in controlled lab conditions so that they stay away from any type of infection. After these specific pathogen free animals are brought out of their bio-secure facility, they lose their status of being specific pathogen free animals.
These animals are housed in a highly controlled environment to prevent infestation by specific categories of pathogens. The term "specific pathogen free" (SPF) does not imply absolute freedom from all types of infections or pathogens; rather, it indicates that these animals must be free from pathogens specified by the supplier in their requirements. These animals are maintained under carefully regulated laboratory conditions to minimize the risk of contamination. Once these specific pathogen-free animals are removed from their biosafety containment, they lose their designated status as pathogen-free animals.
The global market for specific pathogen free animals is fragmented into species and end users.
Based on the species, the global market is segregated into chicken, shrimp, pig, rabbit, mouse, and others.
Based on the end users, the market is categorized into contract research organizations, research institutes, and pharmaceutical companies.
In the recent years, there has been an increase in the prevalence of different diseases, thus there has been a rise in the research activities in the medical sector. These research activities make use of the animals which are healthy and are free of pathogens or infections so that the drug that is being tested is not affected by these conditions. The factor that will restrain the specific pathogen free animals market is the risks that are involved but are not known to the animals as they are only tested for specific pathogens.
Regional diversification of the specific pathogen free animals market is given as follows Eastern Europe, Asia Pacific, Latin America, the Middle East & Africa, Western Europe, and North America. The region that is having an attractive market for the specific pathogen free animals market is the North America and it is anticipated that the market will grow at a fast rate in the coming years. North America is followed by Europe. The factor due to which the market is experiencing such a growth in the North American region is the increased number of contract research organizations and research institutes that are present in this region. Moreover, the government is also supporting by giving funds for the research activities and for the development of the vaccines for different diseases thus propelling the growth of the market in this region. In Asia Pacific region, especially, in the developing nations such as India, China, and South Korea the specific pathogen free animals market will experience a significant growth due to increasing activities in the research and the developing biotechnology market.
The key market players that are involved in specific pathogen free animals market include
Market by Type
Market by Application
What Reports Provides